Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

Merryn Voysey (second from right) pictured with (left to right) Doone Roisin Hansen, Tom Hooper and Jamie Dornan - picture credit Albert Palen © Albert Palen

Professor Voysey was honoured by awards organizers the Australia Day Foundation for her successful career as a researcher in vaccinology and work as the lead methodologist for the Oxford vaccine trials.

She said: ‘I’m extremely honoured to receive this award. Medical research is very much a team sport, and the achievements of the last two years were the result of the hard work of many hundreds of people.

‘It was an honour and a privilege to work on the development of this vaccine and to know that so many lives have been saved as a result.’

Read the full story on the University of Oxford website

Similar stories

Oxford expands the Cartography collaboration with Janssen

The University of Oxford announced today that it has expanded a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation

Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment

A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.

Oxford team to begin novel coronavirus vaccine research

A research team at Oxford University’s Jenner Institute is preparing to begin clinical testing of a novel coronavirus vaccine candidate.

New MERS vaccine clinical trial starts in Saudi Arabia

The King Abdullah International Medical Research Centre (KAIMRC), in collaboration with the University of Oxford’s Jenner Institute has started a Phase I clinical trial in the Kingdom of Saudi Arabia (KSA) for a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

Typhoid vaccine over 81% effective in tackling disease in Nepal

A large field study of typhoid conjugate vaccine (TCV) in Nepal has shown a single dose to be safe and effective in reducing typhoid in children aged 9 months to <16 years in an endemic setting.

International neglect of typhoid outside rich countries threatens a new global health emergency

The emergence of untreatable strains of typhoid threatens a new global health emergency that requires urgent collective action, argue experts from the Oxford Martin School in the journal Clinical Infectious Diseases today.